Beech Hill Advisors’s Medicines Co MDCO Stock Holding History

Beech Hill Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-6,350	Closed	-$245K	–	153
2013 Q4	$245K	Buy	+6,350	New	+$227K	0.12%	118

Other funds holding MDCO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Beech Hill Advisors's MDCO Position: Q1 2014 in Review

Beech Hill Advisors sold out of Medicines Co (MDCO) in Q1 2014, closing a stake of 6,350 shares — an estimated $245K sold.

Beech Hill Advisors first reported a position in MDCO in Q4 2013 and held it in 1 quarter. The position peaked at $245K in Q4 2013. 166 funds tracked by Wall St. Rank hold MDCO as of Q1 2014.

Beech Hill Advisors reported no remaining Medicines Co position as of Q1 2014 after selling out during the quarter.
Beech Hill Advisors sold 6,350 Medicines Co shares in Q1 2014, an estimated $245K.
Beech Hill Advisors first reported a position in Medicines Co in Q4 2013 and held it in 1 quarter.
Beech Hill Advisors's Medicines Co position peaked at $245K in Q4 2013.
166 funds tracked by Wall St. Rank held Medicines Co as of Q1 2014.

Based on Beech Hill Advisors's 13F filing for Q1 2014, filed 25 Apr 2014.